Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Mirai Bio has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Mirai Bio's investors include Flagship Pioneering.
Mirai Bio is headquartered in Cambridge, United States.
Mirai Bio provides access to end-to-end development capabilities with innovation at every step.
Mirai Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mirai Bio — Funding & Investors." VCBacked, September 26, 2024, https://www.vcbacked.co/company/mirai-bio. Accessed September 30, 2026.
VCBacked. (2024). Mirai Bio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mirai-bio
{{cite web |title=Mirai Bio — Funding & Investors |url=https://www.vcbacked.co/company/mirai-bio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated